This Article supports SDG 3 by showing that there is a high global seroprevalence of HCV infection among pregnant women (estimated at 2.2–5.3 million cases worldwide), and particularly in lower-income settings. The authors suggest policy implications, such as expanding screening programmes for pregnant women and women of childbearing age, particularly in lower-income settings.